Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @QIAGEN
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @QIAGEN
-
Prikvačeni tweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Meet us next week at Medlab 2020, Dubai. Check out our portfolio: https://www.omnia-health.com/exhibitor/qiagen …
Booth number Z5.C10
3rd Feb 2020 ‐ 6th Feb 2020
Dubai International Convention & Exhibition Centre
#FromSampleToInsightpic.twitter.com/IpocoPfMs5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joining @see_aso right now in Abidjan, working on bringing more LTBI testing solutions to the business in Ivory Coast!
#StopTB#EndTBpic.twitter.com/aBTFdXxQJY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
After watching, go to Qiastat-Dxhttps://qiastat-dx.com/?source=CM_ID_ID_Qiastat-flu_0129_SM_Twitterorg …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What do Ct values bring to the interpretation of respiratory testing results? Dr. Utsav Pandey explains how his lab uses Ct values and amplification curves from the QIAstat-Dx Respiratory Panel to provide a more informed interpretationhttps://youtu.be/GGbn7LTdkeY?t=942 …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Europe: FluNewsEurope - https://flunewseurope.org/
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Flu season is here, with many areas of the U.S. reporting high activity. Keep up to date with the latest in your region here: US: CDC -https://www.cdc.gov/flu/weekly/index.htm#ILIMap …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
“Treating latent TB means fewer drugs, fewer side effects, and shorter times for therapy.” - Dr. Eskild Petersen, Ministry of Health, Oman | Learn how
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Important milestone for many patients to be tested for the JAK2 V617F mutation which presence is established as one of the major diagnostic criteria for MPN in the WHO 2016 guideline for the classification of myeloid neoplasms and acute leukemia: https://doi.org/10.1182/blood-2016-03-643544 …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
(QIAGEN is the exclusive worldwide licensee of intellectual property rights that cover the detection of the V617F JAK2 mutation for diagnostic purposes.)
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The new kit is based on the ipsogen JAK2 RGQ PCR Kit developed and commercialized by QIAGEN as an IVD in major markets around the world including US and Europe. More information about ipsogen JAK2 RGQ PCR Kit: https://www.qiagen.com/products/diagnostics-and-clinical-research/oncology/ipsogen-leukemia/ipsogen-jak2-rgq-pcr-kit-ce/#orderinginformation …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sysmex launches first IVD JAK2V617F Gene Mutation Testing for Myeloproliferative Neoplasms covered under health insurance in Japan: ipsogen JAK2 DX Reagent.https://www.sysmex.co.jp/en/news/2020/200106.html …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Over 175,000
#oncology cases have been processed by QCI Precision Insights so far. We are excited about the launch of QCI Precision Insights in Europe!Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Head over to
#Instagram -@DannyJamesWard finished a#365DaysOfScience challenge last year and we asked him some questions about#SciComm and his current research
https://twitter.com/DannyJamesWard/status/1217860286717231106 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
QIAGEN proslijedio/la je Tweet
Delighted to be featured in a
@QIAGEN post over on Instagram. Head over to the link to read more about the#Science and#SciComm work I do including the#365DaysOfScience challenge I set myself! https://www.instagram.com/p/B7YreAEIk4B/#PhDChat#GradSchool#AcademicChatter#AcademicTwitter#PhDHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’re proud to have contributed to the new
@AMRAlliance report – see how#biotech companies are helping to curb the spread of#AMR: https://bit.ly/2sPce7f pic.twitter.com/oTxsUMcXhGHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
While
#AMR is one of the greatest threats to#GlobalHealth, 5.7 million people still die from treatable bacterial infections due to a lack of access to#antibiotics. See how@AMRAlliance members are engaging in programmes to address this: https://bit.ly/2sPce7f pic.twitter.com/7HsyRxJ2cQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

Join the QIAGEN Cancer Research Community, a community for dedicated and passionate